Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 3
This trial is comparing with a new drug called BAY 2927088 as a first treatment for non small lung cell lung cancer.
It is for people with non small cell lung cancer who:
have a change () in a called HER2
have not had treatment for their cancer
Recruitment start: 28 August 2024
Recruitment end: 17 April 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ajay Mehta
Bayer
Last reviewed: 29 April 2025
CRUK internal database number: 19965